DermaBind TL
Commercial- Indications
- Non-healing wounds
Company intelligence / Profile preview
Healthtech Wound Care commercializes FDA-compliant dehydrated placental membrane allograft wound coverings such as DermaBind™, used in treating burns, post-surgical wounds, diabetic foot ulcers, and chronic skin wounds. The products are covered by Medicare and distributed nationwide through established healthcare channels. Clinical results highlight their use as natural biological barriers that maintain native protein structure to support healing in non-healing wounds[1][4].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Healthtech Wound Care.